Abstract
Movement disorders characteristically result from dysfunction at the level of the basal ganglia and are classified into two broad groups: hypokinetic and hyperkinetic movement disorders. Patients with hypokinetic movement disorders have reduced movements, such as rigidity and akinesia/bradykinesia, which are primarily reported in the context of rigid-akinetic forms of Parkinson disease. Hyperkinetic movement disorders are characterised by excessive movements and include a wide range of motor manifestations, including tremor (rhythmic oscillatory movements), chorea (abrupt, purposeless, dance-like movements), athetosis (continuous, writhing movements, often involving the extremities and occasionally combined with chorea: ‘choreoathetosis’), tics (sudden, repetitive movements and vocalisations expressed following a sensory urge), dystonia (slow, twisting movements and abnormal postures caused by sustained or intermittent muscle contractions), myoclonus (brief shock-like jerks due to the sudden contraction or relaxation of one or more muscles), mannerisms (gestures and peculiar movements that individualise a person and are not usually considered bothersome), and stereotypies (patterned, repetitive, seemingly purposeless movements or utterances typically present in the context of autism spectrum disorders). Both neurodegenerative (Parkinson disease, Huntington disease) and neurodevelopmental (Tourette syndrome) movement disorders often present with specific behavioural symptoms which have a deep impact on patients’ health-related quality of life and highly benefit from a comprehensive neuropsychiatric approach.
Every psychiatric disorder is accompanied by abnormal movements; movement disorders such as Parkinson disease invariably have associated mental state changes and Tourette syndrome is not simply a tic disorder
Michael Trimble, The Intentional Brain (2016)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Books
Albanese A, Jankovic J, editors. Hyperkinetic movement disorders. Oxford: Wiley; 2012.
Bédard M-A, Agid Y, Chouinard S, Fahn S, Korczyn AD, Lespérance P, editors. Mental and behavioral dysfunction in movement disorders. Totowa: Humana Press; 2003.
Burn D, editor. Oxford textbook of movement disorders. Oxford: Oxford University Press; 2013.
Donaldson IM, Marsden CD, Schneider SA, Bhatia KP. Marsden’s book of movement disorders. Oxford: Oxford University Press; 2012.
Fahn S, Jankovic J, Hallett M. Principles and practice of movement disorders. 2nd ed. Philadelphia: Elsevier; 2011.
Kurlan RM, Green PE, Biglan KM. Hyperkinetic movement disorders. Oxford: Oxford University Press; 2015.
Martino D, Espay AJ, Fasano A, Morgante F. Disorders of movement. New York: Springer; 2016.
Reichmann H, editor. Neuropsychiatric symptoms of movement disorders. New York: Springer; 2015.
Rogers D. Motor disorder in psychiatry: towards a neurological psychiatry. Chichester: John Wiley & Sons; 1992.
Watts RL, Standaert DG, Obeso JA, editors. Movement disorders. 3rd ed. New York: McGraw-Hill; 2011.
Articles
Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol. 2010;6:29–37.
Cavanna AE. The behavioural neurology of basal ganglia disorders. Behav Neurol. 2013;26:217–8.
Chou KL, Borek LL, Friedman JH. The management of psychosis in movement disorder patients. Expert Opin Pharmacother. 2007;8:935–43.
Fahn S. Classification of movement disorders. Mov Disord. 2011;26:947–57.
Jahanshahi M, Obeso I, Rothwell JC, Obeso JA. A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition. Nat Rev Neurosci. 2015;16:719–32.
Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009;8:844–56.
Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016;17:2461–70.
Kieburtz K, Olanow CW. Advances in clinical trials for movement disorders. Mov Disord. 2015;30:1580–7.
Lanska DJ. The history of movement disorders. Handb Clin Neurol. 2010;95:501–46.
Macerollo A, Martino D. What is new in tics, dystonia and chorea? Clin Med. 2016;16:383–9.
Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ. The expanding universe of disorders of the basal ganglia. Lancet. 2014;384:523–31.
Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014;13:100–12.
Pietracupa S, Bruno E, Cavanna AE, Falla M, Zappia M, Colosimo C. Scales for hyperkinetic disorders: a systematic review. J Neurol Sci. 2015;358:9–21.
Schroll H, Hamker FH. Basal ganglia dysfunctions in movement disorders: what can be learned from computational simulations. Mov Disord. 2016;31:1591–601.
Stoessl AJ, Mckeown MJ. Movement disorders. Handb Clin Neurol. 2016;136:957–69.
Stoessl AJ, Lehericy S, Strafella AP. Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia. Lancet. 2014;384:532–44.
Ward P, Seri S, Cavanna AE. Functional neuroanatomy and behavioural correlates of the basal ganglia: evidence from lesion studies. Behav Neurol. 2013;26:219–23.
Wider C, Wszolek ZK. Movement disorders: insights into mechanisms and hopes for treatment. Lancet Neurol. 2009;8:8–10.
Websites
International Parkinson and Movement Disorders Society. www.movementdisorders.org
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Cavanna, A.E. (2018). Classification of Movement Disorders. In: Motion and Emotion. Springer, Cham. https://doi.org/10.1007/978-3-319-89330-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-89330-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89329-7
Online ISBN: 978-3-319-89330-3
eBook Packages: MedicineMedicine (R0)